Investment Rating - The industry investment rating for basic chemicals and oil & gas is maintained at "Overweight" [6] Core Viewpoints - The industry is experiencing a bottoming phase in profitability for bulk chemicals in 2024, with signs of recovery in downstream demand beginning in Q1 2025 [2][19] - The oil price has been under pressure due to geopolitical tensions and OPEC+ production cuts, leading to a decline in profitability across the oil and gas value chain [10][14] - The overall revenue for the basic chemicals and oil & gas sector in 2024 was 1,031.71 billion, with a net profit of 49.85 billion, reflecting a year-on-year decline of 1% and 0.8% respectively [12][18] Summary by Sections 2024 Annual Overview - The oil and gas sector remains relatively strong, while bulk cyclical products are facing profitability challenges [3][14] - The chemical industry is waiting for a supply-demand turning point, with 21 out of 35 sub-industries showing positive performance in A-shares [14][16] Q1 2025 Performance - In Q1 2025, the oil price decline has led to a decrease in profitability for the oil and gas sector, while downstream products are showing initial signs of recovery [19][20] - The revenue for Q1 2025 was 25,157 billion, with a net profit of 1,426 billion, indicating a year-on-year decline of 4% and 3% respectively, but a quarter-on-quarter increase of 2% and 78% [12][23] Industry Outlook - The second half of 2025 is expected to see an upward trend, driven by improved domestic and external demand, as well as capital expenditure recovery [5][10] - Recommended stocks include Meihua Biological, Xinghuo Technology, and others, which are expected to benefit from the recovery in the chemical industry [8][5]

广东肇庆星湖生物科技股份有限公司 简式权益变动报告书 上市公司名称：广东肇庆星湖生物科技股份有限公司 股票上市地点：上海证券交易所 股票简称：星湖科技 股票代码：600866 信息披露义务人：铁小荣 住所：宁夏银川市金凤区森林公园首善花园 通讯地址：宁夏银川市金凤区森林公园首善花园 信息披露义务人的一致行动人：宁夏伊品投资集团有限公司 住所：银川市永宁县望远镇金盛物流信息中心4号楼423号房 通讯地址：宁夏银川市金凤区德宁国际中心 股份变动性质：减持股份 签署日期：2025年5月7日 1 二、信息披露义务人签署本报告书已获得必要的授权和批准，其履行亦不违反信息 披露义务人合伙协议或内部规则中的任何条款，或与之相冲突。 三、依据《中华人民共和国证券法》《上市公司收购管理办法》《公开发行证券的公 司信息披露内容与格式准则第 15 号——权益变动报告书》的规定，本报告书已全面披露 了信息披露义务人及其一致行动人在广东肇庆星湖生物科技股份有限公司(以下简称"星 湖科技"、公司、上市公司)中拥有权益的股份变动情况。 四、截至本报告书签署之日，除本报告书披露的信息外，上述信息披露义务人没有 通过任何其他方式增加或减少其在 ...

股票代码：600866 股票简称：星湖科技 公告编号：临 2025-021 ● 本次权益变动不会导致公司控股股东、实际控制人发生变 化。 ● 本次权益变动后，铁小荣及其一致行动人宁夏伊品投资集 团 有 限 公 司 （ 以 下 简 称 " 伊 品 集 团 " ） 合 计 持 有 公 司 股 份 249,220,980股，持股比例降至15.00%。 2025年5月7日，公司收到持股5%以上股东铁小荣及其一致行动 人伊品集团出具的《简式权益变动报告书》，2025年4月22日至2025 年5月6日期间，铁小荣通过大宗交易及集中竞价交易方式合计减持 公司股份33,693,800股，减持后持股比例降至15.00%。现将本次权 益变动的具体情况公告如下： 一、本次权益变动基本情况 （一）信息披露义务人基本信息 | 信息披露 | 名称 | 铁小荣及其一致行动人伊品集团 | | --- | --- | --- | | | | 铁小荣：宁夏银川市金凤区森林公园首善花园 | | 义务人基 | 住所 | 伊品集团：宁夏银川市永宁县望远镇金盛物流信息中心4 | | 本信息 | | | | | | 号楼423号房 | （二）本次权益变动 ...

Core Viewpoint - The company achieved a net profit of 1.142 billion yuan after deducting non-recurring items in 2024, representing a year-on-year increase of 57.07%, primarily due to a significant increase in product sales [1][3]. Financial Performance - The company reported an operating income of 17.334 billion yuan in 2024, a slight decrease of 0.23% year-on-year. The net profit attributable to shareholders was 943 million yuan, up 39.12% year-on-year, while the net profit after deducting non-recurring items was 1.142 billion yuan, reflecting a 57.07% increase [3]. - For Q1 2025, the company achieved a total operating income of 4.039 billion yuan, a decrease of 3.82% year-on-year, but the net profit after deducting non-recurring items was 462 million yuan, showing an impressive year-on-year growth of 81.61% [4]. Dividend Distribution - The company plans to distribute a cash dividend of 0.38 yuan per share (before tax), with an estimated total cash dividend of approximately 631.36 million yuan (before tax), accounting for 66.94% of the net profit attributable to shareholders [3]. Future Profit Forecast - The company forecasts net profits attributable to shareholders for 2025, 2026, and 2027 to be 1.318 billion yuan, 1.433 billion yuan, and 1.601 billion yuan, respectively, with corresponding EPS of 0.79, 0.86, and 0.96 yuan [2]. Project Development - The company is accelerating the construction of a 600,000-ton corn deep processing and supporting cogeneration project, aiming for trial production by the end of 2025, with a total investment of approximately 3.712 billion yuan [4]. - The company is also steadily advancing the nucleotides technical transformation project in Zhaodong, with an investment of 167.29 million yuan, expected to take 16 months [4].

Investment Rating - The report indicates a positive outlook for the chemical industry, suggesting a new cycle may begin due to improved domestic supply and demand, increased global market share, and declining crude oil prices [3][4]. Core Viewpoints - The chemical industry is expected to enter a new cycle driven by domestic supply-demand improvements and global market share growth, despite potential short-term impacts from overseas demand [3][5]. - The report highlights that the supply side is gradually improving due to reduced fixed asset investment growth and government policies aimed at curbing excessive competition [5][10]. - On the demand side, domestic consumption is anticipated to recover steadily, supported by government initiatives to boost consumption and stabilize the economy [26][33]. - Cost factors are favorable, with significant declines in international crude oil and domestic coal prices, which will support the profitability of chemical products [42][49]. - The report recommends specific companies within various segments of the chemical industry, including refrigerants, amino acids, military and new materials, and fertilizers, indicating potential investment opportunities [5][57]. Summary by Sections Supply Side - The report notes that the chemical industry has faced profitability pressures since 2022, but the current production cycle is nearing its end, which may lead to gradual improvement in profitability as capacity is digested [11][12]. - China's global market share in chemical products has been steadily increasing, with 2023 figures showing a 43.1% share of global sales [25][20]. Demand Side - The report emphasizes that domestic demand is expected to recover, aided by government policies aimed at stimulating consumption and investment [26][33]. - The real estate sector shows signs of stabilization, which could further support demand for chemical products [33]. Cost Side - The report highlights a significant decline in crude oil prices, with Brent crude falling by 14.71% since the beginning of 2025, which is expected to positively impact the cost structure of the chemical industry [42][38]. - Domestic coal and natural gas prices have also shown a downward trend, enhancing the cost competitiveness of chemical products [49][47]. Valuation - The report indicates that the valuation of the basic chemical and petrochemical sectors is at historical lows, suggesting substantial room for recovery as market conditions improve [54][50].

截至2025年4月30日收盘，星湖科技(600866)报收于7.56元，下跌1.05%，换手率3.45%，成交量38.24万 手，成交额2.92亿元。 董秘最新回复 投资者： 去年请问出口美国收入多少？ 董秘： 尊敬的投资者，您好！在国际市场上，公司产品远销欧洲、东南亚、韩国等50多个国家与地 区，公司2024年度国外整体销售收入情况请详见公司于2025年4月22日在上海证券交易所披露的临2025- 011号《2024年度主要经营数据公告》。感谢您的关注！ 投资者： 请问，截止4月25日收盘，股东户数多少？ 董秘： 尊敬的投资者，您好！关于公司的股东户数请详见公司于2025年4月22日在上海证券交易所披露 的《2025年第一季度报告》，感谢您的关注！ 投资者： 董秘您好，根据美国对中国的最新关税政策，对公司影响有多大，是否可以进行成本转移， 公司对美国出口的营业收入占比有多少，未来对美业务规划如何。 董秘： 尊敬的投资者，您好！在国际市场上，公司产品远销欧洲、东南亚、韩国等50多个国家与地 区，目前美国对中国的关税政策不会对公司的生产经营产生重大影响。公司将密切关注国际经济环境及 相关政策的变化，积极研究和制 ...

广东肇庆星湖生物科技股份有限公司 关于持股5%以上股东权益变动触及1%整数倍的 提示性公告 股票代码：600866 股票简称：星湖科技 公告编号：临 2025-020 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性 承担法律责任。 重要内容提示： ● 本次权益变动系广东肇庆星湖生物科技股份有限公司（以 下简称"公司"）持股5%以上的股东铁小荣履行此前披露的减持计 划，不触及要约收购。 ● 本次权益变动不会导致公司控股股东、实际控制人发生变 化。 ● 本次权益变动后，铁小荣及其一致行动人宁夏伊品投资集 团 有 限 公 司 （ 以 下 简 称 " 伊 品 集 团 " ） 合 计 持 有 公 司 股 份 265,250,180股，持股比例从17.03%减少至15.96%。 2025年4月23日，公司收到持股5%以上股东铁小荣及其一致行动 人伊品集团出具的《关于权益变动触及1%整数倍的告知函》，现将 本次权益变动的具体情况公告如下： 一、本次权益变动基本情况 （一）信息披露义务人基本信息 | 信息披露 | 名称 | 铁小荣及其一致行动人伊品集团 | ...

（文章来源：证券时报网） 证券时报·数据宝统计，4月22日共有49只个股现身大宗交易平台，累计成交量0.51亿股，累计成交额 5.72亿元，其中19只个股交易额超千万元。唯捷创芯交易额最高，大宗交易共1笔，成交额0.49亿元；其 次是星湖科技，大宗交易共1笔，成交额0.47亿元。（数据宝） 4月22日大宗交易成交额居前股票 | 证券代 | 证券简 | 涨幅 | 收盘价 | 成交量（万 | 成交额（万 | 笔 | 成交价 | 折溢价 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 码 | 称 | （%） | （元） | 股） | 元） | 数 | （元） | （%） | | 688153 | 唯捷创 | -1.21 | 34.38 | 150.00 | 4875.00 | 1 | 32.50 | -5.47 | | | 芯 | | | | | | | | | 600866 | 星湖科 技 | 10.04 | 7.89 | 600.00 | 4734.00 | 1 | 7.89 | 0.00 | | 603266 | 天龙股 份 | 2.02 ...

Investment Rating - The report maintains a "Recommended" rating for the company, indicating a potential upside of over 15% relative to the benchmark index [4]. Core Views - The company has demonstrated strong profit growth, with a 39.12% year-on-year increase in net profit for 2024, driven by effective cost control and increased sales volume despite a slight decline in revenue [1][2]. - The market for feed amino acids is experiencing significant growth, with a compound annual growth rate (CAGR) of 12.7%, which is expected to benefit the company as it focuses on small variety amino acids [3]. - The company is investing 37.12 billion yuan in a corn deep processing project, which is anticipated to enhance its competitive edge in the amino acid market [3]. Financial Performance Summary - In 2024, the company achieved a revenue of 173.34 billion yuan, a slight decrease of 0.23% year-on-year, while net profit reached 9.43 billion yuan, an increase of 39.12% [1]. - For Q1 2025, the company reported a revenue of 40.39 billion yuan, down 3.82% year-on-year, but net profit surged by 88.55% to 4.74 billion yuan [1][2]. - The gross profit margin improved significantly, reaching 22.46% in Q1 2025, compared to 17.19% in 2024, reflecting better cost management [2]. Business Segment Overview - In 2024, the company generated revenue from various segments: food additives (4.25 billion yuan), feed additives (11.73 billion yuan), and others, with respective gross margins of 12.24% and 16.97% [2]. - The company’s overall profit margins improved, with net profit margin reaching 5.48% in 2024, up from previous levels [2]. Future Earnings Forecast - The company is projected to achieve net profits of 13.05 billion yuan, 14.48 billion yuan, and 16.16 billion yuan for 2025, 2026, and 2027 respectively, with corresponding earnings per share (EPS) of 0.79 yuan, 0.87 yuan, and 0.97 yuan [3][5].

星湖科技4 月21 日发布24 年年报和25 年一季报：24 年营收173 亿元，同比-0.2%，归母净利9.4 亿元 （扣非后11.4 亿元），同比39%（扣非后同比57%），其中24Q4 归母净利2.7 亿元，同环比 +41%/+55%，24Q4 归母净利符合我们前瞻2.7 亿元的预期。拟每股派现0.38 元（含税），股利支付率 66.94%。25Q1 实现营收40 亿元，同环比-4%/-11%，归母净利4.7 亿元（扣非后4.6 亿元），同环比 89%/78%，25Q1 归母净利超过我们前瞻3亿元的预期，系成本改善、非经常性损益减少等影响。考虑豆 粕提价及减量替代需求下氨基酸景气有望改善，维持"买入"评级。 24 年氨基酸景气改善，味精跌价及非经常性损益拖累下全年净利仍创新高24 年饲料添加剂营收yoy+4% 至117 亿元，毛利率yoy+4.8pct 至17%，据博亚和讯，赖氨酸（98.5%）/赖氨酸（70%）/苏氨酸均价 10.5/5.3/11.0 元/kg ， yoy+11%/-9%/+1% ， 赖/ 苏氨酸综合价差2.4/3.8 元/kg ，yoy+94%/+60%；食品添 加剂营收yoy-13 ...